Competitor Insights for Soft Tissue Repair

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

METHODOLOGY

1.0 GLOBAL SOFT TISSUE REPAIR MARKET

• 1.1 US Soft Tissue Repair Market
• 1.2 European Soft Tissue Repair Market
• 1.3 Japanese Soft Tissue Repair Market
• 1.4 Competitive Analysis

2.0 C.R. BARD

• 2.1 Company Overview
• 2.2 Recent Events/Strategy
• 2.3 Products Offered
• 2.4 Global Sales Performance
  • 2.4.1 US
  • 2.4.2 Europe
  • 2.4.3 Japan
• 2.5 S.W.O.T. Analysis
  • 2.5.1 Strengths
  • 2.5.2 Weaknesses
  • 2.5.3 Opportunities
  • 2.5.4 Threats

3.0 GYNECARE

• 3.1 Company Overview
• 3.2 Recent Events/Strategy
• 3.3 Products Offered
• 3.4 Global Sales Performance
  • 3.4.1 US
  • 3.4.2 Europe
  • 3.4.3 Japan
• 3.5 S.W.O.T. Analysis
  • 3.5.1 Strengths
  • 3.5.2 Weaknesses
  • 3.5.3 Opportunities
  • 3.5.4 Threats

4.0 W.L. GORE

• 4.1 Company Overview
• 4.2 Recent Events/Strategy
• 4.3 Products Offered
• 4.4 Global Sales Performance
  • 4.4.1 US
  • 4.4.2 Europe
  • 4.4.3 Japan
• 4.5 S.W.O.T. Analysis
  • 4.5.1 Strengths
  • 4.5.2 Weaknesses
  • 4.5.3 Opportunities
  • 4.5.4 Threats

5.0 ETHICON

• 5.1 Company Overview
• 5.2 Recent Events/Strategy
• 5.3 Products Offered
• 5.4 Global Sales Performance
  • 5.4.1 US
  • 5.4.2 Europe
  • 5.4.3 Japan
• 5.5 S.W.O.T. Analysis
  • 5.5.1 Strengths
  • 5.5.2 Weaknesses
  • 5.5.3 Opportunities
  • 5.5.4 Threats

6.0 AMERICAN MEDICAL SYSTEMS

• 6.1 Company Overview
• 6.2 Recent Events/Strategy
• 6.3 Products Offered
• 6.4 Global Sales Performance
  • 6.4.1 US
  • 6.4.2 Europe
  • 6.4.3 Japan
• 6.5 S.W.O. T. Analysis
  • 6.5.1 Strengths
  • 6.5.2 Weaknesses
  • 6.5.3 Opportunities
  • 6.5.4 Threats

7.0 SYNOVIS LIFE TECHNOLOGIES

• 7.1 Company Overview
• 7.2 Recent Events/Strategy
• 7.3 Products Offered
• 7.4 Global Sales Performance
  • 7.4.1 US
  • 7.4.2 Europe
• 7.5 S.W.O.T. Analysis
  • 7.5.1 Strengths
  • 7.5.2 Weaknesses
  • 7.5.3 Opportunities
  • 7.5.4 Threats

8.0 BOSTON SCIENTIFIC

• 8.1 Company Overview
• 8.2 Recent Events/Strategy
• 8.3 Products Offered
• 8.4 Global Sales Performance
• 8.5 S.W.O. T. Analysis
  • 8.5.1 Strengths
  • 8.5.2 Weaknesses
  • 8.5.3 Opportunities
  • 8.5.4 Threats

9.0 SOFRADIM

• 9.1 Company Overview
• 9.2 Recent Events/Strategy
• 9.3 Products Offered
• 9.4 Global Sales Performance
  • 9.4.1 US
  • 9.4.2 Europe
• 9.5 S.W.O. T. Analysis
  • 9.5.1 Strengths
  • 9.5.2 Weaknesses
  • 9.5.3 Opportunities
  • 9.5.4 Threats

10.0 MENTOR

• 10.1 Company Overview
• 10.2 Recent Events/Stra tegy
• 10.3 Products Offered
• 10.4 Glob al Sales Performance
  • 10.4.1 US
  • 10.4.2 Europe
• 10.5 S.W.O. T. Analysis
  • 10.5.1 Strengths
  • 10.5.2 Weaknesses
  • 10.5.3 Opportunities
  • 10.5.4 Threats

11.0 COOK

• 11.1 Company Overview
• 11.2 Recent Events/Strategy
• 11.3 Products Offered
• 11.4 Global Sales Performance
  • 11.4.1 US
  • 11.4.2 Europe
  • 11.4.3 Japan
• 11.5 S.W.O.T. Analysis
  • 11.5.1 Strengths
  • 11.5.2 Weaknesses
  • 11.5.3 Opportunities
  • 11.5.4 Threats

APPENDIX A: MRG ACRONYMS AND INITIALISMS